Oxford Nanopore Technologies /£ONT

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc, trading under the ticker ONT, operates in the biotechnology sector, focusing on the development of nanopore technology for DNA and RNA sequencing. Founded in 2005 and publicly listed, the company's innovative technology facilitates real-time, scalable, and accessible biological research, with applications ranging from healthcare to environmental science. Based in the UK, Oxford Nanopore has revolutionized the approach to molecular analysis by providing a direct and electric characterization of single molecules.

Ticker

£ONT
Sector

Primary listing

LSE

Employees

1,325

ONT Metrics

BasicAdvanced
£1.6B
-
-£0.15
0.85
-

What the Analysts think about ONT

Analyst ratings (Buy, Hold, Sell) for Oxford Nanopore Technologies stock.

Bulls say / Bears say

The company expects fiscal‐year 2025 revenue of approximately £183 million, up 8% from 2023, driven by expansion into applied industrial, biopharma, and clinical sectors, underscoring successful diversification beyond research markets (Reuters).
Oxford Nanopore reaffirmed its medium‐term financial targets, including achieving adjusted EBITDA break‐even by 2027 and positive cash flow by 2028, providing a clear roadmap to profitability (Reuters).
Major investors such as Larry Ellison and Novo Holdings have maintained or increased their stakes, reflecting strong institutional confidence in the company’s long‐term prospects despite market volatility (Financial Times).
The share price has plunged about 85% from its 2021 peak, highlighting significant investor disappointment and potential valuation concerns (Financial Times).
The firm faces material uncertainty, with 10–15% of revenues tied to U.S. federal funding via the NIH and export control tightening further threatening revenue growth in 2025 (Reuters).
A £6 million charge for a 5% workforce reduction in early 2025 underscores ongoing cost pressures, which may hamper operational scalability and innovation efforts (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.

ONT Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ONT Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £ONT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs